Download PDF
Thorac Cardiovasc Surg 2000; 48(2): 114-119
DOI: 10.1055/s-2000-9868
Review
© Georg Thieme Verlag Stuttgart · New York

Thymic Carcinoma - Analysis of Nineteen Clinicopathological Studies

D. A. Chung
  • Department of Cardiothoracic Surgery, Papworth Hospital, Cambridge, UK
Further Information

Publication History

January 17, 2000

Publication Date:
31 December 2000 (online)

    Permissions and Reprints All articles of this category

Background: Primary thymic carcinomas are rare tumours with nonuniform management protocols and poor prognosis due to delayed diagnosis and highly malignant behaviour. This review summarises the major clinicopathological studies to assess more fully the prognostic importance of tumour histology and staging as well as treatment benefit. Methods: A Medline search from 1966 to date was carried out and relevant references gleaned from these. Nineteen clinicopathological studies form the core of this review. Demographic data and clinical features were examined in all studies. Correlation of outcome with histology was possible in fifteen of the studies and with tumour staging in thirteen. Results: Thymic carcinomas occur most commonly in the fifth to sixth decades of life, usually presenting with symptoms of space occupation or invasion. Paraneoplastic syndromes are rarely associated, except with the well differentiated thymic carcinoma. Of 140 thymic carcinomas, 40 were squamous cell, 19 were spindle cell and 16 were lymphoepithelioma-like. Completely resected stage I and II tumours demonstrated the best survival. Conclusions: Complete surgical resection is taken to be the desired treatment, but the continued high mortality and relapse rates and the variable benefit of adjuvant therapies challenge this strategy.

Key words:

Thymus - Thymic carcinoma - Surgery - Radiotherapy - Chemotherapy

References

  • 1 Levine G D, Rosai J. Thymic hyperplasia and neoplasia: a review of current concepts.  Hum Pathol.. 1978;  9 495-514
    PubMedGoogle Scholar
  • 2 Wick M R, Weiland L H, Scheithauer B W, Bernatz P E. Primary thymic carcinomas.  Am J Surg Pathol.. 1982;  6 451-70
    PubMedGoogle Scholar
  • 3 Shimosato Y, Kameya T, Nagai K, Suemasu K. Squamous cell carcinoma of the thymus. An analysis of eight cases.  Am J Surg Pathol.. 1977;  1 109-21
    PubMedGoogle Scholar
  • 4 Snover D C, Levine G D, Rosai J. Thymic carcinoma: five distinct histological variants.  Am J Surg Pathol.. 1982;  6 451-70
    PubMedGoogle Scholar
  • 5 Truong L D, Mody D R, Cagle P T, Jackson-York G L, Schwartz M R, Wheeler T M. Thymic carcinoma. A clinicopathologic study of 13 cases.  Am J Surg Pathol.. 1990;  14 151-66
    PubMedGoogle Scholar
  • 6 Hartmann C-A, Roth Chr, Minck C, Niedobitek G. Thymic carcinoma. Report of five cases and review of the literature.  J Cancer Res Clin Oncol.. 1990;  116 69-82
    CrossrefPubMedGoogle Scholar
  • 7 Kuo T-t, Chang J-P, Lin F-J, Wu W-C, Chang C-H. Thymic carcinomas: histopathological varieties and immunohistochemical study.  Am J Surg Pathol.. 1990;  14 24-34
    PubMedGoogle Scholar
  • 8 Suster S, Rosai J. Thymic carcinoma: a clinicopathologic study of 60 cases.  Cancer.. 1991;  67 1025-32
    PubMedGoogle Scholar
  • 9 Chang H K, Wang C H, Liaw C C, Ng K T, Chang J P, Chen M S, Kuo T T, Lai G M. Prognosis of thymic carcinoma: analysis of 16 cases.  J Formos Med Assoc.. 1992;  91 764-9
    PubMedGoogle Scholar
  • 10 Pescarmona E, Rosati S, Rendina E A, Venuta F, Baroni C D. Well-differentiated thymic carcinoma: a clinico-pathologic study.  Virchows Arch A Pathol Anat Histopathol.. 1992;  420 179-83
    PubMedGoogle Scholar
  • 11 Yano T, Hara N, Ichinose Y, Asoh H, Yokoyama H, Ohta M. Treatment and prognosis of primary thymic carcinoma.  J Surg Oncol.. 1993;  52 255-8
    PubMedGoogle Scholar
  • 12 Weide L G, Ulbright T M, Loehrer P J, Williams S D. Thymic carcinoma. A distinct clinical entity responsive to chemotherapy.  Cancer.. 1993;  71 219-23
    PubMedGoogle Scholar
  • 13 Tsuchiya R, Koga K, Matsuno Y, Mukai K, Shimosato Y. Thymic carcinoma: proposal for pathological TNM and staging.  Pathol Int.. 1994;  44 505-12
    PubMedGoogle Scholar
  • 14 Hsu C-P, Cheng C-Y, Chen C-L, Lin C-T, Hsu N-Y, Wang J-H, Wang P-Y. Thymic carcinoma. Ten years' experience in twenty patients.  J Thorac Cardiovasc Surg.. 1994;  107 615-20
    PubMedGoogle Scholar
  • 15 Shimizu J, Hayashi Y, Morita K, Arano Y, Yoshida M, Oda M, Murakami S, Watanabe Y, Nonomura A. Primary thymic carcinoma: a clinicopathological and immunohistochemical study.  J Surg Oncol.. 1994;  56 159-64
    PubMedGoogle Scholar
  • 16 Hasserjian R P, Klimstra D S, Rosai J. Carcinoma of the thymus with clear cell features. Report of eight cases and review of the literature.  Am J Surg Pathol.. 1995;  19 835-41
    PubMedGoogle Scholar
  • 17 Suster S, Moran C A. Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma. A cinicopathologic study of 22 cases.  Am J Surg Pathol.. 1996;  20 1469-80
    CrossrefPubMedGoogle Scholar
  • 18 Blumberg D, Burt M E, Bains M S, Downey R J, Martini N, Rusch V, Ginsberg R J. Thymic carcinoma: current staging does not predict prognosis.  J Thorac Cardiovasc Surg.. 1998;  115 303-8
    CrossrefPubMedGoogle Scholar
  • 19 Matsuno Y, Morozumi N, Hiroshashi S, Shimosato Y, Rosai J. Papillary carcinoma of the thymus: report of four cases of a new microscopic type of thymic carcinoma.  Am J Surg Pathol.. 1998;  22 873-80
    CrossrefPubMedGoogle Scholar
  • 20 Suster S, Moran C A. Spindle cell thymic carcinoma: clinicopathologic and immunohistochemical study of a distinctive variant of primary thymic epithelial neoplasm.  Am J Surg Pathol.. 1999;  23 691-700
    CrossrefPubMedGoogle Scholar
  • 21 Masaoka A, Monden Y, Nakahara K, Tanaka T. Follow-up study of thymomas with reference to their clinical stages.  Cancer.. 1981;  48 2485-92
    CrossrefPubMedGoogle Scholar
  • 22 Marino M, Müller-Hermelink H K. Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of the thymus.  Virchows Arch A Pathol Anat Histopathol.. 1985;  407 119-49
    CrossrefPubMedGoogle Scholar
  • 23 Kirchner T, Müller-Hermelink H K. New approaches to the diagnosis of thymic epithelial tumors.  Prog Surg Pathol.. 1989;  10 167-89
    PubMedGoogle Scholar
  • 24 Masaoka A, Yamakawa Y, Fujii Y. Well-differentiated thymic carcinoma: is it thymic carcinoma or not?.  J Thorac Cardiovasc Surg.. 1999;  117 628-30
    PubMedGoogle Scholar
  • 25 Suster S, Moran C A. Thymoma, atypical thymoma, and thymic carcinoma. A novel conceptual approach to the classification of thymic epithelial neoplasms.  Am J Surg Pathol.. 1999;  111 826-33
    PubMedGoogle Scholar
  • 26 Rosai J, Higa E. Mediastinal endocrine neoplasm of probable thymic origin, related to carcinoid tumor: clinico-pathologic study of 8 cases.  Cancer.. 1972;  29 1061-74
    PubMedGoogle Scholar
  • 27 Rosai J, Levine G, Weber W R, Higa E. Carcinoid tumors and oat cell carcinomas of the thymus.  Eng Path Ann.. 1976;  11 201-26
    PubMedGoogle Scholar
  • 28 Fukai I, Masaoka A, Fujii Y, Yamakawa Y, Yokoyama T, Murase T, Eimoto T. Thymic neuroendocrine tumor (thymic carcinoid): a clinicopathologic study in 15 patients.  Ann Thorac Surg.. 1999;  67 208-11
    CrossrefPubMedGoogle Scholar
  • 29 Lauriola L, Erlandson R A, Rosai J. Neuroendocrine differentiation is a common feature of thymic carcinoma.  Am J Surg Pathol.. 1998;  22 1059-66
    CrossrefPubMedGoogle Scholar
  • 30 Hishima T, Fukayama M, Arai K, Shiozawa Y, Funata N, Koike M. Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma.  Hum Pathol.. 1998;  29 330-8
    CrossrefPubMedGoogle Scholar
  • 31 Travis W D, Linnoila M G, Hitchcock C L, Cutler G B Jr, Nieman L, Chrousos G, Pass H, Doppman J. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma.  Am J Surg Pathol.. 1991;  15 529-53
    CrossrefPubMedGoogle Scholar
  • 32 Suster S, Moran C A. Thymic carcinoma: spectrum of differentiation and histologic types.  Pathology.. 1998;  30 111-22
    PubMedGoogle Scholar
  • 33 Kuo T-t, Chan J K. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile.  Am J Surg Pathol.. 1998;  22 1474-81
    CrossrefPubMedGoogle Scholar
  • 34 Leyvraz S, Henle W, Chahinian H P, Klein G, Gordon R E, Rosenblum M, Holland J F. Association of Epstein-Barr virus with thymic carcinoma.  N Engl J Med.. 1985;  312 1296-9
    PubMedGoogle Scholar
  • 35 Thomas C V, Manivel J C. Thymic carcinoma and aplastic anemia: report of a previously undocumented association.  Am J Hematol.. 1987;  25 333-5
    PubMedGoogle Scholar
  • 36 Suzuki K, Tanaka H, Shibusa T, Shibuya Y, Inuzuka M, Fujishima T, Abe S. Parathyroid-hormone-related-protein-producing thymic carcinoma presenting as a giant extrathoracic mass.  Respiration.. 1998;  65 83-5
    CrossrefPubMedGoogle Scholar
  • 37 Do Y S, Im J G, Kim K H, Oh Y W, Chin S Y, Zo J I, Jang J J. CT findings in malignant tumors of thymic epithelium.  J Comput Assist Tomogr.. 1995;  19 192-7
    PubMedGoogle Scholar
  • 38 Yamakawa Y, Masaoka A, Hashimoto T, Niwa H, Mizuno T, Fujii Y, Nakahara K. A tentative tumor-node-metastasis classification of thymoma.  Cancer.. 1991;  68 1984-7
    CrossrefPubMedGoogle Scholar
  • 39 Uematsu M, Kondo M. A proposal for treatment of invasive thymoma.  Cancer.. 1986;  58 1979-84
    PubMedGoogle Scholar
  • 40 Ariaratnum L S, Kalnicki S, Mincer F, Botstein C. The management of malignant thymoma with radiation therapy.  Int J Radiat Oncol Biol Phys.. 1979;  5 77-80
    PubMedGoogle Scholar
  • 41 Carlson R W, Dorfman R F, Sikic B I. Successful treatment of metastatic thymic carcinoma with cisplatin, vinblastine, bleomycin, and etoposide chemotherapy.  Cancer.. 1990;  66 2092-4
    PubMedGoogle Scholar

D. A. Chung

Department of Cardiothoracic Surgery

Papworth Hospital Cambridges CB3 8RE UK

Phone: Phone +44-1480-830541

Fax: Fax +44-1480-364338

Email: E-mail: surjun@hotmail.com

      >